West Pharmaceutical Services, Inc. (WST) — 分析摘要
West Pharmaceutical Services, Inc.(WST)的市值为25.41十亿美元,最近一年的营收同比增长了+6.3%。净利润率为16.1%。当前市盈率为46.8倍。
核心要点
- 营收同比变化+6.3%
- 净利润率16.1%
- 市盈率46.8倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比,WST的营收增长为+6.3%,市盈率为46.8倍。
West Pharmaceutical Services, Inc. (WST)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报,没有触发重大的信用、利润率或趋势红旗。
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
10,800
总部
EXTON, PA
Exchange
XNYS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析,不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
年度每股股息
$0.88
股息收益率
0.25%
股息历史
免责声明:本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。